ELIZABETH WHEELER: Open Payments
NPI 1255895009 · ROSWELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$721 in 39 payments from 19 companies in 2025. Trend: 2023 $1,112 · 2024 $770 · 2025 $721
Food & beverage: $721
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $95 |
| PFIZER INC. | 5 | $83 |
| Lilly USA, LLC | 4 | $72 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| Janssen Pharmaceuticals, Inc | 2 | $51 |
| GlaxoSmithKline, LLC. | 3 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $44 |
| Xeris Pharmaceuticals, Inc. | 2 | $38 |
| Medtronic, Inc. | 2 | $38 |
| SANOFI-AVENTIS U.S. LLC | 2 | $34 |
Products named: MOUNJARO, Ozempic, SPRAVATO, Kerendia, GVOKE HYPOPEN, MINIMED 780G, AIRSUPRA, ELIQUIS.
Industry payments across GA — which companies pay providers there.
